Bruderman Asset Management’s Celgene Corp CELG Stock Holding History

Bruderman Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-393	Closed	-$37K	–	667
2019 Q1	$37K	Hold	393	–	–	0.01%	306
2018 Q4	$25K	Buy	+393	New	+$29K	0.01%	323
2016 Q2	–	Sell	-2	Closed	–	–	413
2016 Q1	$0	Buy	+2	New	+$206	﹤0.01%	428
2015 Q3	–	Sell	-42	Closed	-$5K	–	469
2015 Q2	$5K	Buy	42 +40	+2,000%	+$4.57K	﹤0.01%	395
2015 Q1	$0	Buy	+2	New	+$239	﹤0.01%	431

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bruderman Asset Management's CELG Position: Q2 2019 in Review

Bruderman Asset Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 393 shares — an estimated $37K sold.

Bruderman Asset Management first reported a position in CELG in Q1 2015 and held it in 5 quarters. The position peaked at $37K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Bruderman Asset Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Bruderman Asset Management sold 393 Celgene Corp shares in Q2 2019, an estimated $37K.
Bruderman Asset Management first reported a position in Celgene Corp in Q1 2015 and held it in 5 quarters.
Bruderman Asset Management's Celgene Corp position peaked at $37K in Q1 2019.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.